Bottom line
BIS vs FAS: the short answer
BIS (ProShares UltraShort Nasdaq Biotechnology) and FAS (Direxion Daily Financial Bull 3X ETF) are both etfs.
But FAS is far broader, holding 88 positions to 9 for BIS, so beyond the top names it adds exposure BIS doesn't have.
FAS is cheaper at 0.88% vs 0.95% — a difference of $7.00 a year per $10,000 invested.
Over five years, FAS returned +25.9% a year vs −15.1% for BIS.
Updated Nov 19, 2026
BIS vs FAS side by side
| BIS | FAS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.95% | 0.88% |
| Annual cost per $10k | $95 | $88 |
| 10-yr cost on $10k (prospectus) | $3,943 | $1,128 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | −46.1% | +21.4% |
| 5-yr return (annualized) | −15.1% | +25.9% |
| 10-yr return (annualized) | −21.2% | +21.1% |
| Best quarter | +51.5% | +79.1% |
| Worst quarter | −43.0% | −75.1% |
| Net assets (fund) | $2.4M | $2.3B |
| Number of holdings | 9 | 88 |
| Portfolio turnover | % | 66% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BIS | FAS | Difference |
|---|---|---|---|
| 2025 | −46.1% | +21.4% | −67.5% |
| 2024 | +5.0% | +84.5% | −79.5% |
| 2023 | −6.3% | +14.5% | −20.9% |
| 2022 | −2.5% | −43.1% | +40.6% |
| 2021 | −14.8% | +116.6% | −131.4% |
| 2020 | −56.0% | −35.2% | −20.8% |
| 2019 | −40.8% | +113.1% | −153.9% |
| 2018 | +5.0% | −33.6% | +38.6% |
| 2017 | −37.2% | +67.0% | −104.2% |
| 2016 | +22.0% | +40.6% | −18.6% |
Source: Fund prospectus bar charts
Holdings overlap
5 of BIS's top 9 holdings also appear in FAS's top 25.
| Holding | BIS | FAS |
|---|---|---|
| N/a | -3.64% | 1.02% |
| N/a | -3.75% | 1.02% |
| N/a | -10.52% | 1.02% |
| N/a | -11.12% | 1.02% |
| N/a | -16.39% | 1.02% |
Source: SEC Form N-PORT
BIS top 10
- Repurchase Agreement — 40.64%
- Repurchase Agreement — 25.57%
- Repurchase Agreement — 19.18%
- Repurchase Agreement — 14.06%
- N/a — -3.64%
- N/a — -3.75%
- N/a — -10.52%
- N/a — -11.12%
- N/a — -16.39%
FAS top 10
- Dreyfus — 21.14%
- Goldman Financial — 9.03%
- Jp Morgan Chase & Company — 7.91%
- Berkshire Hathaway Inc — 7.87%
- Visa Inc — 5.10%
- Mastercard Inc — 3.88%
- Bank Of America Corp — 3.40%
- N/a — 3.07%
- N/a — 2.64%
- Goldman Sachs Group Inc (the) — 2.52%
FAQ
What is the difference between BIS and FAS?
Which is cheaper, BIS or FAS?
Should I own both BIS and FAS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.